Atlas Trials

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Clinical trial NCT05357612 · RECRUITING

Trial details

NCT number
NCT05357612
Sponsor
Vanderbilt University Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Start date
2023-01-23
Primary completion
2027-06-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.